It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Addictive substance use impairs cognitive flexibility, with unclear underlying mechanisms. The reinforcement of substance use is mediated by the striatal direct-pathway medium spiny neurons (dMSNs) that project to the substantia nigra pars reticulata (SNr). Cognitive flexibility is mediated by striatal cholinergic interneurons (CINs), which receive extensive striatal inhibition. Here, we hypothesized that increased dMSN activity induced by substance use inhibits CINs, reducing cognitive flexibility. We found that cocaine administration in rodents caused long-lasting potentiation of local inhibitory dMSN-to-CIN transmission and decreased CIN firing in the dorsomedial striatum (DMS), a brain region critical for cognitive flexibility. Moreover, chemogenetic and time-locked optogenetic inhibition of DMS CINs suppressed flexibility of goal-directed behavior in instrumental reversal learning tasks. Notably, rabies-mediated tracing and physiological studies showed that SNr-projecting dMSNs, which mediate reinforcement, sent axonal collaterals to inhibit DMS CINs, which mediate flexibility. Our findings demonstrate that the local inhibitory dMSN-to-CIN circuit mediates the reinforcement-induced deficits in cognitive flexibility.
Addictive substances may impair cognitive flexibility. Here the authors show that in rodents, increased activity of striatal direct-pathway medium spiny neurons (dMSNs) in response to cocaine inhibits cholinergic interneurons (CINs), reducing cognitive flexibility.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Wang, Xuehua 2 ; Lu, Jiayi 2 ; Zhuang, Xiaowen 2 ; Essoh, Amanda 2 ; Huang, Yufei 1 ; Chen, Ruifeng 3 ; Smith, Laura N. 1
; Smith, Rachel J. 4 ; Wang, Jun 5
1 Texas A&M University Health Science Center, Department of Neuroscience and Experimental Therapeutics, School of Medicine, Bryan, USA (GRID:grid.412408.b); Texas A&M University, Institute for Neuroscience, College Station, USA (GRID:grid.264756.4) (ISNI:0000 0004 4687 2082)
2 Texas A&M University Health Science Center, Department of Neuroscience and Experimental Therapeutics, School of Medicine, Bryan, USA (GRID:grid.412408.b)
3 Texas A&M University Health Science Center, Department of Neuroscience and Experimental Therapeutics, School of Medicine, Bryan, USA (GRID:grid.412408.b); Texas A&M University, Interdisciplinary Faculty of Toxicology, College Station, USA (GRID:grid.264756.4) (ISNI:0000 0004 4687 2082)
4 Texas A&M University, Institute for Neuroscience, College Station, USA (GRID:grid.264756.4) (ISNI:0000 0004 4687 2082); Texas A&M University, Department of Psychological and Brain Sciences, College Station, USA (GRID:grid.264756.4) (ISNI:0000 0004 4687 2082)
5 Texas A&M University Health Science Center, Department of Neuroscience and Experimental Therapeutics, School of Medicine, Bryan, USA (GRID:grid.412408.b); Texas A&M University, Institute for Neuroscience, College Station, USA (GRID:grid.264756.4) (ISNI:0000 0004 4687 2082); Texas A&M University, Interdisciplinary Faculty of Toxicology, College Station, USA (GRID:grid.264756.4) (ISNI:0000 0004 4687 2082)




